OSA's Digital Library

Optics Express

Optics Express

  • Editor: Andrew M. Weiner
  • Vol. 21, Iss. 20 — Oct. 7, 2013
  • pp: 24129–24138

Far-red fluorescence gene reporter tomography for determination of placement and viability of cell-based gene therapies

Yujie Lu, Chinmay D. Darne, I-Chih Tan, Banghe Zhu, Mary A. Hall, ZaWaunyka W. Lazard, Alan R. Davis, LaShan Simpson, Eva M. Sevick-Muraca, and Elizabeth A. Olmsted-Davis  »View Author Affiliations


Optics Express, Vol. 21, Issue 20, pp. 24129-24138 (2013)
http://dx.doi.org/10.1364/OE.21.024129


View Full Text Article

Enhanced HTML    Acrobat PDF (2270 KB)





Browse Journals / Lookup Meetings

Browse by Journal and Year


   


Lookup Conference Papers

Close Browse Journals / Lookup Meetings

Article Tools

Share
Citations

Abstract

Non-invasive injectable cellular therapeutic strategies based on sustained delivery of physiological levels of BMP-2 for spinal fusion are emerging as promising alternatives, which could provide sufficient fusion without the associated surgical risks. However, these injectable therapies are dependent on bone formation occurring only at the specific target region. In this study, we developed and deployed fluorescence gene reporter tomography (FGRT) to provide information on in vivo cell localization and viability. This information is sought to confirm the ideal placement of the materials with respect to the area where early bone reaction is required, ultimately providing three dimensional data about the future fusion. However, because almost all conventional fluorescence gene reporters require visible excitation wavelengths, current in vivo imaging of fluorescent proteins is limited by high tissue absorption and confounding autofluorescence. We previously administered fibroblasts engineered to produce BMP-2, but is difficult to determine 3-D information of placement prior to bone formation. Herein we used the far-red fluorescence gene reporter, IFP1.4 to report the position and viability of fibroblasts and developed 3-D tomography to provide placement information. A custom small animal, far-red fluorescence tomography system integrated into a commercial CT scanner was used to assess IFP1.4 fluorescence and to demark 3-D placement of encapsulated fibroblasts with respect to the vertebrae and early bone formation as assessed from CT. The results from three experiments showed that the placement of the materials within the spine could be detected. This work shows that in vivo fluorescence gene reporter tomography of cell-based gene therapy is feasible and could help guide cell-based therapies in preclinical models.

© 2013 Optical Society of America

OCIS Codes
(110.6960) Imaging systems : Tomography
(170.3010) Medical optics and biotechnology : Image reconstruction techniques
(170.6280) Medical optics and biotechnology : Spectroscopy, fluorescence and luminescence

ToC Category:
Medical Optics and Biotechnology

History
Original Manuscript: June 4, 2013
Revised Manuscript: September 2, 2013
Manuscript Accepted: September 15, 2013
Published: October 2, 2013

Citation
Yujie Lu, Chinmay D. Darne, I-Chih Tan, Banghe Zhu, Mary A. Hall, ZaWaunyka W. Lazard, Alan R. Davis, LaShan Simpson, Eva M. Sevick-Muraca, and Elizabeth A. Olmsted-Davis, "Far-red fluorescence gene reporter tomography for determination of placement and viability of cell-based gene therapies," Opt. Express 21, 24129-24138 (2013)
http://www.opticsinfobase.org/oe/abstract.cfm?URI=oe-21-20-24129


Sort:  Author  |  Year  |  Journal  |  Reset  

References

  1. A. S. Mistry and A. G. Mikos, “Tissue engineering strategies for bone regeneration,” Adv. Biochem. Eng. Biotechnol.94, 1–22 (2005). [CrossRef] [PubMed]
  2. M. Miyazaki, H. Tsumura, J. C. Wang, and A. Alanay, “An update on bone substitutes for spinal fusion,” Eur. Spine J.18(6), 783–799 (2009). [CrossRef] [PubMed]
  3. U. Heise, J. F. Osborn, and F. Duwe, “Hydroxyapatite ceramic as a bone substitute,” Int. Orthop.14(3), 329–338 (1990). [CrossRef] [PubMed]
  4. H. S. An, K. Lynch, and J. Toth, “Prospective comparison of autograft vs. allograft for adult posterolateral lumbar spine fusion: differences among freeze-dried, frozen, and mixed grafts,” J. Spinal Disord.8(2), 131–135 (1995). [CrossRef] [PubMed]
  5. M. P. Lutolf, F. E. Weber, H. G. Schmoekel, J. C. Schense, T. Kohler, R. Müller, and J. A. Hubbell, “Repair of bone defects using synthetic mimetics of collagenous extracellular matrices,” Nat. Biotechnol.21(5), 513–518 (2003). [CrossRef] [PubMed]
  6. M. Bikram, C. Fouletier-Dilling, J. A. Hipp, F. Gannon, A. R. Davis, E. A. Olmsted-Davis, and J. L. West, “Endochondral bone formation from hydrogel carriers loaded with BMP2-transduced cells,” Ann. Biomed. Eng.35(5), 796–807 (2007). [CrossRef] [PubMed]
  7. N. Ferrara, K. Houck, L. Jakeman, and D. W. Leung, “Molecular and biological properties of the vascular endothelial growth factor family of proteins,” Endocr. Rev.13(1), 18–32 (1992). [PubMed]
  8. A. Minamide, M. Yoshida, M. Kawakami, S. Yamasaki, H. Kojima, H. Hashizume, and S. D. Boden, “The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion,” Spine30(10), 1134–1138 (2005). [CrossRef] [PubMed]
  9. M. R. Urist, “Bone: formation by autoinduction,” Science150(3698), 893–899 (1965). [CrossRef] [PubMed]
  10. G. B. Bishop and T. A. Einhorn, “Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery,” Int. Orthop.31(6), 721–727 (2007). [CrossRef] [PubMed]
  11. K. S. Cahill, J. H. Chi, A. Day, and E. B. Claus, “Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures,” JAMA302(1), 58–66 (2009). [CrossRef] [PubMed]
  12. R. M. Olabisi, Z. W. W. Lazard, C. L. Franco, M. A. Hall, S. K. Kwon, E. M. Sevick-Muraca, J. A. Hipp, A. R. Davis, E. A. Olmsted-Davis, and J. L. West, “Hydrogel microsphere encapsulation of a cell-based gene therapy system increases cell survival of injected cells, transgene expression, and bone volume in a model of heterotopic ossification,” Tissue Eng. Part A16(12), 3727–3736 (2010). [CrossRef] [PubMed]
  13. A. Vaccaro, “Bone morphogenetic protein and their complications,” J. Bone Joint Surg. Br.94, 169 (2012).
  14. R. M. Olabisi, Z. Lazard, M. H. Heggeness, K. M. Moran, J. A. Hipp, A. K. Dewan, A. R. Davis, J. L. West, and E. A. Olmsted-Davis, “An injectable method for noninvasive spine fusion,” Spine J.11(6), 545–556 (2011). [CrossRef] [PubMed]
  15. R. Y. Tsien, “Constructing and exploiting the fluorescent protein paintbox (Nobel Lecture),” Angew. Chem. Int. Ed. Engl.48(31), 5612–5626 (2009). [CrossRef] [PubMed]
  16. K. E. Adams, S. Ke, S. Kwon, F. Liang, Z. Fan, Y. Lu, K. Hirschi, M. E. Mawad, M. A. Barry, and E. M. Sevick-Muraca, “Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer,” J. Biomed. Opt.12(2), 024017 (2007). [CrossRef] [PubMed]
  17. X. Shu, A. Royant, M. Z. Lin, T. A. Aguilera, V. Lev-Ram, P. A. Steinbach, and R. Y. Tsien, “Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome,” Science324(5928), 804–807 (2009). [CrossRef] [PubMed]
  18. G. S. Filonov, K. D. Piatkevich, L. M. Ting, J. Zhang, K. Kim, and V. V. Verkhusha, “Bright and stable near-infrared fluorescent protein for in vivo imaging,” Nat. Biotechnol.29(8), 757–761 (2011). [CrossRef] [PubMed]
  19. B. T. Feeley, A. H. Conduah, O. Sugiyama, L. Krenek, I. S. Y. Chen, and J. R. Lieberman, “In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models,” J. Orthop. Res.24(8), 1709–1721 (2006). [CrossRef] [PubMed]
  20. Z. Gugala, E. A. Olmsted-Davis, F. H. Gannon, R. W. Lindsey, and A. R. Davis, “Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type,” Gene Ther.10(16), 1289–1296 (2003). [CrossRef] [PubMed]
  21. C. D. Darne, Y. Lu, I. C. Tan, B. Zhu, J. C. Rasmussen, A. M. Smith, S. Yan, and E. M. Sevick-Muraca, “A compact frequency-domain photon migration system for integration into commercial hybrid small animal imaging scanners for fluorescence tomography,” Phys. Med. Biol.57(24), 8135–8152 (2012). [CrossRef] [PubMed]
  22. A. D. Klose and E. W. Larsen, “Light transport in biological tissue based on the simplified spherical harmonics equations,” J. Comput. Phys.220(1), 441–470 (2006). [CrossRef]
  23. M. Chu, K. Vishwanath, A. D. Klose, and H. Dehghani, “Light transport in biological tissue using three-dimensional frequency-domain simplified spherical harmonics equations,” Phys. Med. Biol.54(8), 2493–2509 (2009). [CrossRef] [PubMed]
  24. Y. Lu, B. Zhu, H. Shen, J. C. Rasmussen, G. Wang, and E. M. Sevick-Muraca, “A parallel adaptive finite element simplified spherical harmonics approximation solver for frequency domain fluorescence molecular imaging,” Phys. Med. Biol.55(16), 4625–4645 (2010). [CrossRef] [PubMed]
  25. Y. Lu, B. Zhu, C. Darne, I. C. Tan, J. C. Rasmussen, and E. M. Sevick-Muraca, “Improvement of fluorescence-enhanced optical tomography with improved optical filtering and accurate model-based reconstruction algorithms,” J. Biomed. Opt.16(12), 126002 (2011). [CrossRef] [PubMed]
  26. Y. Lu, H. B. Machado, A. Douraghy, D. Stout, H. Herschman, and A. F. Chatziioannou, “Experimental bioluminescence tomography with fully parallel radiative-transfer-based reconstruction framework,” Opt. Express17(19), 16681–16695 (2009). [CrossRef] [PubMed]

Cited By

Alert me when this paper is cited

OSA is able to provide readers links to articles that cite this paper by participating in CrossRef's Cited-By Linking service. CrossRef includes content from more than 3000 publishers and societies. In addition to listing OSA journal articles that cite this paper, citing articles from other participating publishers will also be listed.

Figures

Fig. 1 Fig. 2
 

« Previous Article  |  Next Article »

OSA is a member of CrossRef.

CrossCheck Deposited